- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
HealthAmigo and AvantGo push health info out to PDAs
HealthAmigo, a company providing medical data over the Web and mobile Internet, and AvantGo, a firm providing wireless information and services, have joined forces to launch HealthAmigo's Pocket Doctor service for PDAs. While the service is
HealthAmigo, a company providing medical data over the Web and mobile Internet, and AvantGo, a firm providing wireless information and services, have joined forces to launch HealthAmigo's Pocket Doctor service for PDAs. While the service is available only over WAP-enabled phones, the two companies plan to use the higher memory and storage capacity of PDAs to make Pocket Doctor available on both the Palm OS and Windows CE platforms.
The Health-E-Ref application, for example, allows users to download an entire medical encyclopedia to their PDAs, and DoctorQ, the other service targeted for the initial PDA platform launch, outlines questions that patients should ask their doctors in specific situations. HealthAmigo is targeting the global healthcare consumer market and will make Pocket Doctor available in multiple languages, according to Rob Wilson, managing director.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
